Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 11 studies | 39% ± 17% | |
epithelial cell | 5 studies | 21% ± 3% | |
fibroblast | 5 studies | 19% ± 2% | |
GABAergic neuron | 4 studies | 35% ± 6% | |
astrocyte | 4 studies | 36% ± 14% | |
oligodendrocyte precursor cell | 4 studies | 25% ± 8% | |
microglial cell | 3 studies | 22% ± 1% | |
hepatocyte | 3 studies | 52% ± 23% | |
glutamatergic neuron | 3 studies | 46% ± 3% | |
macrophage | 3 studies | 20% ± 1% | |
adipocyte | 3 studies | 25% ± 3% | |
oligodendrocyte | 3 studies | 23% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 31% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1696.19 | 1445 / 1445 | 100% | 36.63 | 183 / 183 |
ovary | 100% | 2156.58 | 180 / 180 | 100% | 29.18 | 430 / 430 |
lung | 100% | 1926.16 | 577 / 578 | 100% | 40.04 | 1153 / 1155 |
breast | 100% | 2631.77 | 459 / 459 | 100% | 37.16 | 1114 / 1118 |
stomach | 100% | 1228.54 | 359 / 359 | 99% | 30.88 | 284 / 286 |
intestine | 100% | 1759.73 | 966 / 966 | 99% | 22.53 | 520 / 527 |
brain | 99% | 984.30 | 2618 / 2642 | 100% | 26.86 | 702 / 705 |
uterus | 100% | 2888.97 | 170 / 170 | 98% | 28.67 | 452 / 459 |
kidney | 100% | 1312.81 | 89 / 89 | 98% | 32.62 | 886 / 901 |
skin | 100% | 2451.06 | 1809 / 1809 | 98% | 37.35 | 464 / 472 |
prostate | 100% | 1503.86 | 245 / 245 | 98% | 24.19 | 493 / 502 |
thymus | 100% | 2948.17 | 653 / 653 | 98% | 84.98 | 593 / 605 |
bladder | 100% | 2053.52 | 21 / 21 | 95% | 21.59 | 479 / 504 |
adrenal gland | 97% | 1124.63 | 251 / 258 | 94% | 25.84 | 216 / 230 |
pancreas | 93% | 735.20 | 304 / 328 | 98% | 40.97 | 175 / 178 |
liver | 99% | 1012.58 | 224 / 226 | 88% | 18.55 | 356 / 406 |
adipose | 100% | 2558.71 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3079.58 | 1335 / 1335 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.93 | 1 / 1 |
spleen | 99% | 771.46 | 238 / 241 | 0% | 0 | 0 / 0 |
muscle | 98% | 1140.22 | 786 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 1450.77 | 838 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 23.49 | 43 / 45 |
eye | 0% | 0 | 0 / 0 | 86% | 12.52 | 69 / 80 |
lymph node | 0% | 0 | 0 / 0 | 52% | 7.09 | 15 / 29 |
peripheral blood | 19% | 94.21 | 178 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060037 | Biological process | pharyngeal system development |
GO_0032924 | Biological process | activin receptor signaling pathway |
GO_0003148 | Biological process | outflow tract septum morphogenesis |
GO_0071773 | Biological process | cellular response to BMP stimulus |
GO_0001701 | Biological process | in utero embryonic development |
GO_0003272 | Biological process | endocardial cushion formation |
GO_0001755 | Biological process | neural crest cell migration |
GO_0003274 | Biological process | endocardial cushion fusion |
GO_0007507 | Biological process | heart development |
GO_0009968 | Biological process | negative regulation of signal transduction |
GO_0007368 | Biological process | determination of left/right symmetry |
GO_0003183 | Biological process | mitral valve morphogenesis |
GO_0003181 | Biological process | atrioventricular valve morphogenesis |
GO_0060391 | Biological process | positive regulation of SMAD protein signal transduction |
GO_0002526 | Biological process | acute inflammatory response |
GO_0071363 | Biological process | cellular response to growth factor stimulus |
GO_0032926 | Biological process | negative regulation of activin receptor signaling pathway |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0060923 | Biological process | cardiac muscle cell fate commitment |
GO_0009953 | Biological process | dorsal/ventral pattern formation |
GO_0030509 | Biological process | BMP signaling pathway |
GO_0001569 | Biological process | branching involved in blood vessel morphogenesis |
GO_0062043 | Biological process | positive regulation of cardiac epithelial to mesenchymal transition |
GO_0050731 | Biological process | positive regulation of peptidyl-tyrosine phosphorylation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0001707 | Biological process | mesoderm formation |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0007281 | Biological process | germ cell development |
GO_0051145 | Biological process | smooth muscle cell differentiation |
GO_0060412 | Biological process | ventricular septum morphogenesis |
GO_2001237 | Biological process | negative regulation of extrinsic apoptotic signaling pathway |
GO_2000134 | Biological process | negative regulation of G1/S transition of mitotic cell cycle |
GO_0003289 | Biological process | atrial septum primum morphogenesis |
GO_2000017 | Biological process | positive regulation of determination of dorsal identity |
GO_0006468 | Biological process | protein phosphorylation |
GO_0030278 | Biological process | regulation of ossification |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0030501 | Biological process | positive regulation of bone mineralization |
GO_0061445 | Biological process | endocardial cushion cell fate commitment |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0001702 | Biological process | gastrulation with mouth forming second |
GO_0003143 | Biological process | embryonic heart tube morphogenesis |
GO_0005886 | Cellular component | plasma membrane |
GO_0070724 | Cellular component | BMP receptor complex |
GO_0048179 | Cellular component | activin receptor complex |
GO_0045177 | Cellular component | apical part of cell |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0045296 | Molecular function | cadherin binding |
GO_0017046 | Molecular function | peptide hormone binding |
GO_0098821 | Molecular function | BMP receptor activity |
GO_0046332 | Molecular function | SMAD binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0048185 | Molecular function | activin binding |
GO_1990782 | Molecular function | protein tyrosine kinase binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0050431 | Molecular function | transforming growth factor beta binding |
GO_0004675 | Molecular function | transmembrane receptor protein serine/threonine kinase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005025 | Molecular function | transforming growth factor beta receptor activity, type I |
GO_0005515 | Molecular function | protein binding |
GO_0016361 | Molecular function | activin receptor activity, type I |
Gene name | ACVR1 |
Protein name | receptor protein serine/threonine kinase (EC 2.7.11.30) Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (ACTR-I) (Activin receptor-like kinase 2) (ALK-2) (Serine/threonine-protein kinase receptor R1) (SKR1) (TGF-B superfamily receptor type I) (TSR-I) Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) Serine/threonine-protein kinase receptor (EC 2.7.11.30) Activin A receptor type 1 Alternative protein ACVR1 |
Synonyms | hCG_1811747 ACVRLK2 |
Description | FUNCTION: Bone morphogenetic protein (BMP) type I receptor that is involved in a wide variety of biological processes, including bone, heart, cartilage, nervous, and reproductive system development and regulation . As a type I receptor, forms heterotetrameric receptor complexes with the type II receptors AMHR2, ACVR2A or ACVR2B . Upon binding of ligands such as BMP7 or GDF2/BMP9 to the heteromeric complexes, type II receptors transphosphorylate ACVR1 intracellular domain . In turn, ACVR1 kinase domain is activated and subsequently phosphorylates SMAD1/5/8 proteins that transduce the signal . In addition to its role in mediating BMP pathway-specific signaling, suppresses TGFbeta/activin pathway signaling by interfering with the binding of activin to its type II receptor . Besides canonical SMAD signaling, can activate non-canonical pathways such as p38 mitogen-activated protein kinases/MAPKs (By similarity). May promote the expression of HAMP, potentially via its interaction with BMP6 (By similarity). . |
Accessions | ENST00000410057.6 A0A804HHZ2 ENST00000672582.1 ENST00000684348.1 ENST00000683487.1 ENST00000683426.1 ENST00000682300.1 C9JHJ7 ENST00000263640.7 ENST00000440523.5 ENST00000682025.1 A0A0S2Z2Y3 A0A1B0GXA9 C9JW28 D3DPA4 ENST00000683404.1 A0A804HJQ0 ENST00000412025.5 ENST00000413751.1 ENST00000683441.1 Q04771 ENST00000539637.6 ENST00000434821.7 ENST00000673324.1 ENST00000683820.1 Q53SV1 Q53SF4 ENST00000409283.6 ENST00000424669.6 L8E7H6 A0A0S2Z345 ENST00000684595.1 |